Bio-Techne - TECH Stock Forecast, Price & News

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Bio-Techne in the last twelve months. There are currently 1 sell rating, 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" TECH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TECH, but not buy additional shares or sell existing shares.
View TECH analyst ratings or view top-rated stocks.

5 brokerages have issued twelve-month price targets for Bio-Techne's shares. Their TECH share price forecasts range from $89.00 to $125.00. On average, they anticipate the company's stock price to reach $109.61 in the next twelve months. This suggests a possible upside of 33.8% from the stock's current price.
View analysts price targets for TECH or view top-rated stocks among Wall Street analysts.

Bio-Techne's stock was trading at $129.3350 at the beginning of 2022. Since then, TECH stock has decreased by 36.6% and is now trading at $81.95.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 7th 2023.
View our TECH earnings forecast.

Bio-Techne Co. (NASDAQ:TECH) announced its quarterly earnings data on Tuesday, November, 1st. The biotechnology company reported $0.36 EPS for the quarter, missing analysts' consensus estimates of $0.41 by $0.05. The biotechnology company earned $269.66 million during the quarter, compared to analyst estimates of $281.89 million. Bio-Techne had a net margin of 26.13% and a trailing twelve-month return on equity of 16.37%.

Bio-Techne declared a quarterly dividend on Tuesday, November 1st. Stockholders of record on Monday, November 14th will be paid a dividend of $0.02 per share on Monday, November 28th. This represents a $0.08 dividend on an annualized basis and a dividend yield of 0.10%. The ex-dividend date is Thursday, November 10th.
Read our dividend analysis for TECH.

Bio-Techne (NASDAQ:TECH) pays an annual dividend of $0.32 per share and currently has a dividend yield of 0.40%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 17.93%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, TECH will have a dividend payout ratio of 14.04% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for TECH.

Shares of Bio-Techne split on Wednesday, November 30th 2022. The 4-1 split was announced on Tuesday, November 1st 2022. The newly minted shares were issued to shareholders after the closing bell on Tuesday, November 29th 2022. An investor that had 100 shares of stock prior to the split would have 400 shares after the split.

95 employees have rated Bio-Techne Chief Executive Officer Charles Kummeth on Glassdoor.com. Charles Kummeth has an approval rating of 73% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Bio-Techne investors own include Paychex (PAYX), Gilead Sciences (gild), NVIDIA (NVDA), AbbVie (ABBV), Amgen (AMGN), Abbott Laboratories (ABT), Cisco Systems (CSCO), Johnson & Johnson (JNJ), AT&T (T) and Boeing (BA).

Bio-Techne trades on the NASDAQ under the ticker symbol "TECH."

Bio-Techne's stock is owned by many different institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (11.44%), BlackRock Inc. (11.03%), State Street Corp (4.03%), Neuberger Berman Group LLC (2.64%), Ownership Capital B.V. (1.56%) and Marshall Wace LLP (1.48%). Insiders that own company stock include Alpna Seth, Brenda S Furlow, Brenda S Furlow, Charles R Kummeth, Charles R Kummeth, Glenn Hedde, Harold J Wiens, James Hippel, John L Higgins, Kim Kelderman, Norman David Eansor, Robert V Baumgartner and Roeland Nusse.
View institutional ownership trends.

Shares of TECH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of TECH stock can currently be purchased for approximately $81.95.

Bio-Techne (NASDAQ:TECH) has a market capitalization of $12.86 billion and generates $1.11 billion in revenue each year. The biotechnology company earns $272.05 million in net income (profit) each year or $1.7850 on an earnings per share basis.

The company employs 3,000 workers across the globe.

Bio-Techne's mailing address is 614 MCKINLEY PLACE NE, MINNEAPOLIS MN, 55413. The official website for the company is www.bio-techne.com. The biotechnology company can be reached via phone at (612) 379-8854, via email at ir@bio-techne.com, or via fax at 612-656-4400.